La cadena de opciones muestra datos clave de las opciones de acciones de Getty Images Holdings a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Getty Images Holdings..

Getty Images Holdings (NYSE:GETY) Bolsa, Cadena de Opciones

Getty Images Holdings

Getty Images Holdings Inc is engaged in the core mission of bringing the world's creative and editorial visual content solutions to its customers to engage their audiences. the company has developed market enhancements across e-commerce, content subscriptions, user-generated content, diverse and inclusive content, and proprietary research alongside investment in its technology platform, which includes artificial intelligence and machine learning-driven search functionality and image editing and integrated APIs, to become a trusted industry leader in the visual content. Geographically the company operates in the Americas, Europe, the Middle East, Africa, and Asia-Pacific, out of which a majority of its revenue is generated from the Americas.

Medtronic, Fluor And 3 Stocks To Watch Heading Into Tuesday

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

GETY

SGMO

STNE

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este martes: IHS, HQY, GETY, SGMO y STNE.

5 acciones en el foco este martes: IHS, HQY, GETY, SGMO y STNE

CWCO

SAIC

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este lunes: SAIC, GETY, CTM, CWCO y TSQ.

5 acciones en el foco este lunes: SAIC, GETY, CTM, CWCO y TSQ

Getty Images Holdings, Inc. Class A Common Stock

Getty Images Holdings Inc

Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) CEO Jensen Huang announced Tuesday a partnership with General Motors Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) for its <a href="https://www.benzinga.com/topic/self-driving">self-driving segment</a>.
"The time for autonomous vehicles has arrived,&#8221; Huang said at the GPU Technology Conference (GTC).
GM will build next-generation vehicles on Nvidia Drive AGX, based on the Nvidia Blackwell architecture. The partnership includes factory planning, robotics, in-vehicle hardware for advanced driver-assistance systems and in-cabin safety driving experiences.
"GM has enjoyed a longstanding partnership with NVIDIA, leveraging its GPUS across our operations," GM CEO Mary Barra said in a statement. "AI not only optimizes manufacturing processes and accelerates virtual testing but also helps us build smarter vehicles while empowering our workforce to focus on craftmanship."
Barra said the partnership will allow the automotive company to unlock innovation for vehicle manufacturing.
GM has been investing in Nvidia GPU platforms to train <a href="https://www.benzinga.com/topic/artificial-intelligence">artificial intelligence</a> models. The collaboration now expands to plant design and operations.
"We are thrilled to partner with GM to build AI systems tailored to their vision, craft and know-how," Huang added.
Read Also: <a href="https://www.benzinga.com/tech/25/03/44352209/gtc-2025-could-reignite-nvidias-stock-rally-but-only-if-b300-ai-server-roadmap-and-scaling-concerns-are-addressed-says-top-analyst">GTC 2025 Could Reignite Nvidia&#8217;s Stock Rally, But Only If B300, AI Server Roadmap, And Scaling Concerns Are Addressed, Says Top Analyst</a>
GM wasn&#8217;t the only partnership hyped by Huang at the <a href="https://www.benzinga.com/top-stories/25/03/44313558/nvidia-stock-reached-all-time-highs-after-jensen-huangs-ces-keynote-will-next-weeks-gtc-spark-another-surge">2025 GTC Conference.</a>
"AI is going to go into every industry," Huang said, highlighting the use of Nvidia GPUs in the data center of Tesla vehicles.
<h2 class="wp-block-heading">Huang Shares Excitement For Physical AI, Robotics</h2>
During his GTC keynote, Huang expressed optimism for AI across many sectors, including physical AI, or robotics.
Huang explored an AI timeline and how, over the last 10 years, its focus shifted from generative AI to agentic AI to the new wave, physical AI.
"Artificial intelligence has made extraordinary progress," Huang said, explaining how each wave of AI opens up new market opportunities and new partners.
"A new era of AI we call physical AI,&#8221; he said.
A chart shared by Huang showed the demand for Blackwell GPUs that have just started shipping, which comes from the growth of generative AI, agentic AI and now physical AI.
Huang also announced Nvidia Dynamo, a distributed inference-serving library. The Nvidia CEO said Dynamo is an open-source operating system being used by the company's partners.
At the start of his speech, Huang said GTC has been called the Woodstock of AI in the past and this year it was being called the Super Bowl of AI.
"Everybody wins at this year's Super Bowl."
Price Action: Nvidia stock trades at $115.83 at the time of writing, down 3.1% on the day. Nvidia stock has traded between $75.61 and $153.13 over the last 52 weeks. Shares are down 15% year-to-date in 2025 and up 34% over the last year.
GM stock saw a quick lift from red to green after Huang's announcement. At the time of writing, GM stock was down 1.3% to $48.37. It has a 52-week trading range of $38.96 to $59.39.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="&#x1f534; WATCH LIVE: GTC March 2025 Keynote with NVIDIA CEO Jensen Huang" width="500" height="281" src="https://www.youtube.com/embed/XjZFODtmNhQ?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43991607/nvidia-q4-earnings-highlights-revenue-beat-eps-beat-demand-for-blackwell-is-amazing">Nvidia Q4 Earnings Highlights: Revenue Beat, EPS Beat, &#8216;Demand For Blackwell Is Amazing&#8217;</a></li>
</ul>
Image: Shutterstock

Tech

NVDA

Nvidia CEO Jensen Huang Announces GM Partnership: 'The Time For Autonomous Vehicles Has Arrived'

<ul>
<li>1.6 Terabits Per Second Per Port Switches to Deliver 3.5x Energy Savings and 10x Resilience in AI Factories</li>
<li>Joint Inventions and Collaborations With TSMC, Coherent, Corning Incorporated, Foxconn, Lumentum and SENKO to Create Integrated Silicon, Optics Process and Supply Chain</li>
</ul>

NVIDIA Announces Spectrum-X Photonics

<a href="https://www.youtube.com/watch?v=_waPvOwL9Z8" title="https://www.youtube.com/watch?v=_waPvOwL9Z8">https://www.youtube.com/watch?v=_waPvOwL9Z8</a>

Events

Nvidia Announces Vera Rubin Chip; Vera Rubin Chip Will Be Released In Second Half Of 2026; Nvidia To Release Vera Rubin Ultra In Second Half Of 2027'

Whales with a lot of money to spend have taken a noticeably bullish stance on Chewy.
Looking at options history for Chewy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 50% with bearish.
From the overall spotted trades, 3 are puts, for a total amount of $265,420 and 5, calls, for a total amount of $203,247.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $30.0 and $42.5 for Chewy, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Chewy's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Chewy's substantial trades, within a strike price spectrum from $30.0 to $42.5 over the preceding 30 days.
<h3>Chewy Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742323539_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CHWY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$11.9</td>
<td>$11.8</td>
<td>$11.8</td>
<td>$42.50</td>
<td>$192.3K</td>
<td>2.5K</td>
<td>167</td>
</tr>
<tr>
<td>CHWY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$2.13</td>
<td>$2.12</td>
<td>$2.12</td>
<td>$32.50</td>
<td>$58.4K</td>
<td>6.2K</td>
<td>2.8K</td>
</tr>
<tr>
<td>CHWY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$4.65</td>
<td>$4.6</td>
<td>$4.6</td>
<td>$30.00</td>
<td>$46.0K</td>
<td>708</td>
<td>4</td>
</tr>
<tr>
<td>CHWY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.9</td>
<td>$4.85</td>
<td>$4.9</td>
<td>$30.00</td>
<td>$44.1K</td>
<td>5.2K</td>
<td>186</td>
</tr>
<tr>
<td>CHWY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$2.17</td>
<td>$2.16</td>
<td>$2.17</td>
<td>$32.50</td>
<td>$35.3K</td>
<td>6.2K</td>
<td>3.3K</td>
</tr>
</tbody>
</table>

<h3>About Chewy</h3>
Chewy is the largest e-commerce petcare retailer in the US, generating $11.2 billion in fiscal 2023 sales across pet food, treats, hard goods, and pharmacy categories. The firm was founded in 2011, acquired by PetSmart in 2017, and tapped public markets as a stand-alone company in 2019 after spending a couple of years developing under the aegis of the pet superstore chain. The firm generates sales from pet food, treats, over-the-counter medications, medical prescription fulfillment, and hard goods, like crates, leashes, and bowls.
In light of the recent options history for Chewy, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Chewy's Current Market Status</h3>
<ul>
<li>Trading volume stands at 2,965,375, with CHWY's price down by -4.66%, positioned at $31.5.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 8 days.</li>
</ul>
<h3>What Analysts Are Saying About Chewy</h3>
1 market experts have recently issued ratings for this stock, with a consensus target price of $39.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Wedbush downgraded its action to Outperform with a price target of $39. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Chewy, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

CHWY

Chewy Unusual Options Activity For March 18

Whales with a lot of money to spend have taken a noticeably bearish stance on Lam Research.
Looking at options history for Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) we detected 30 trades.
If we consider the specifics of each trade, it is accurate to state that 36% of the investors opened trades with bullish expectations and 50% with bearish.
From the overall spotted trades, 13 are puts, for a total amount of $691,510 and 17, calls, for a total amount of $1,456,616.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $64.0 to $90.0 for Lam Research over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Lam Research's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Lam Research's whale trades within a strike price range from $64.0 to $90.0 in the last 30 days. 
<h3>Lam Research Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742323534_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$11.55</td>
<td>$11.45</td>
<td>$11.55</td>
<td>$73.00</td>
<td>$282.9K</td>
<td align="right">446</td>
<td align="right">344</td>
</tr>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$10.3</td>
<td>$10.15</td>
<td>$10.3</td>
<td>$75.00</td>
<td>$164.8K</td>
<td align="right">598</td>
<td align="right">330</td>
</tr>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$10.05</td>
<td>$9.9</td>
<td>$10.05</td>
<td>$75.00</td>
<td>$160.8K</td>
<td align="right">598</td>
<td align="right">721</td>
</tr>
<tr>
<td>LRCX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$10.3</td>
<td>$10.0</td>
<td>$10.3</td>
<td>$75.00</td>
<td>$154.5K</td>
<td align="right">598</td>
<td align="right">280</td>
</tr>
<tr>
<td>LRCX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$10.45</td>
<td>$10.35</td>
<td>$10.45</td>
<td>$84.00</td>
<td>$146.3K</td>
<td align="right">912</td>
<td align="right">142</td>
</tr>
</tbody>
</table>

<h3>About Lam Research</h3>
Lam Research is one of the largest semiconductor wafer fabrication equipment manufacturers in the world. It specializes in deposition and etch, which entail the buildup of layers on a semiconductor and the subsequent selective removal of patterns from each layer. Lam holds the top market share in etch and holds the clear second share in deposition. It is more exposed to memory chipmakers for DRAM and NAND chips. It counts as top customers the largest chipmakers in the world, including TSMC, Samsung, Intel, and Micron.
<h3>Where Is Lam Research Standing Right Now?</h3>
<ul>
<li>With a trading volume of 3,775,296, the price of LRCX is down by -1.35%, reaching $77.25.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 36 days from now.</li>
</ul>
<h3>What The Experts Say On Lam Research</h3>
Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $106.25.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Susquehanna upgraded its action to Positive with a price target of $125. 
&#x2A; Maintaining their stance, an analyst from Cantor Fitzgerald continues to hold a Overweight rating for Lam Research, targeting a price of $100. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Outperform rating on Lam Research with a target price of $100. 
&#x2A; Reflecting concerns, an analyst from Cantor Fitzgerald lowers its rating to Overweight with a new price target of $100.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Lam Research with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

LRCX

This Is What Whales Are Betting On Lam Research

Deep-pocketed investors have adopted a bearish approach towards IonQ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IONQ#NYSE">IONQ</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in IONQ usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 12 extraordinary options activities for IonQ. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 50% bearish. Among these notable options, 7 are puts, totaling $341,250, and 5 are calls, amounting to $325,585.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $12.5 to $45.0 for IonQ during the past quarter. 
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for IonQ's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across IonQ's significant trades, within a strike price range of $12.5 to $45.0, over the past month.
<h3>IonQ Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742323529_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>IONQ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$7.2</td>
<td>$7.1</td>
<td>$7.2</td>
<td>$22.50</td>
<td>$121.6K</td>
<td>1.7K</td>
<td align="right">194</td>
</tr>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$4.05</td>
<td>$3.95</td>
<td>$4.04</td>
<td>$45.00</td>
<td>$121.0K</td>
<td>948</td>
<td align="right">303</td>
</tr>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$1.38</td>
<td>$1.31</td>
<td>$1.38</td>
<td>$30.00</td>
<td>$69.0K</td>
<td>7.4K</td>
<td align="right">814</td>
</tr>
<tr>
<td>IONQ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$5.6</td>
<td>$5.4</td>
<td>$5.55</td>
<td>$25.00</td>
<td>$55.4K</td>
<td>1.1K</td>
<td align="right">207</td>
</tr>
<tr>
<td>IONQ</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>04/17/25</td>
<td>$2.73</td>
<td>$2.57</td>
<td>$2.65</td>
<td>$22.50</td>
<td>$53.0K</td>
<td>3.5K</td>
<td align="right">228</td>
</tr>
</tbody>
</table>

<h3>About IonQ</h3>
IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services.
Having examined the options trading patterns of IonQ, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is IonQ Standing Right Now?</h3>
<ul>
<li>With a volume of 15,762,519, the price of IONQ is down -7.66% at $23.02. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 50 days.</li>
</ul>
<h3>Professional Analyst Ratings for IonQ</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $49.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Needham downgraded its action to Buy with a price target of $54. 
&#x2A; Consistent in their evaluation, an analyst from Benchmark keeps a Buy rating on IonQ with a target price of $45. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest IonQ options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

IONQ

IonQ Unusual Options Activity

WIIM

Leishen Energy shares are trading higher. The company reported FY24 financial results.

Strategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) has been a wild ride, surging 90.7% over the past year but slipping 4.48% year-to-date. Now, as the stock struggles below its five-, 20- and 50-day EMAs, the debate over its future is heating up — featuring none other <a href="https://www.benzinga.com/topic/michael-saylor">than Michael Saylor</a> and Peter Schiff in opposing corners.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44376986/strategy-stock-is-sliding-tuesday-whats-going-on">Strategy Stock Is Sliding Tuesday: What&#8217;s Going On?</a>
<h1 class="wp-block-heading">Strategy Stock: A Technical Tug-of-War</h1>
<figure class="wp-block-image size-full"><a href="https://mail.google.com/mail/u/0/?tab=rm&amp;ogbl#inbox/FMfcgzQZTgRMrqRCVhFgxzpKjKzhszFB"><img loading="lazy" decoding="async" width="618" height="487" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18133208/Screenshot-2025-03-18-at-11.01.51-PM.png" alt="" class="wp-image-830047" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18133208/Screenshot-2025-03-18-at-11.01.51-PM.png 618w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18133208/Screenshot-2025-03-18-at-11.01.51-PM-300x236.png 300w" sizes="(max-width: 618px) 100vw, 618px" /></a></figure>
<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
Strategy's current $281.44 stock price is flashing mixed signals:
<ul>
<li>Bullish: The eight-day SMA ($273.26) and 20-day SMA ($277.95) suggest buying pressure is building.</li>
<li>Bearish: The 50-day SMA ($318.59) and the negative MACD (-10.72) signal a downtrend.</li>
<li>Long-term strength: The 200-day SMA ($239.27) still supports the bulls.</li>
</ul>
Despite the volatility, Strategy is ranked as the top momentum stock per <a href="https://www.benzinga.com/screener/top-momentum-stocks">Benzinga&#8217;s Stock Screener Tool</a>, outpacing quantum players like Rigetti Computing Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) and D-Wave Quantum Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>).
<h2 class="wp-block-heading">Saylor's Strife — And Schiff's Slam</h2>
Michael Saylor, Bitcoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) most vocal corporate bull, just doubled down, announcing $STRF (&#8220;Strife&#8221;), a new perpetual preferred stock offering aimed at institutional investors.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">This is ridiculous. It&#39;s a pathetic Hail Mary to keep the air from coming out of the Bitcoin bubble. The only thing keeping it from deflating completely is the Trump administration&#39;s support. Once that goes, it&#39;s all over for Bitcoin and <a href="https://twitter.com/search?q=%24MSTR&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$MSTR</a>.
&mdash; Peter Schiff (@PeterSchiff) <a href="https://twitter.com/PeterSchiff/status/1902005322027319555?ref_src=twsrc%5Etfw">March 18, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
But gold bug and crypto critic Peter Schiff wasn't having it.
&#8220;This is ridiculous. It&#8217;s a pathetic Hail Mary to keep the air from coming out of the Bitcoin bubble,&#8221; Schiff declared, warning that once the Trump administration's backing disappears, &#8220;it's all over for Bitcoin and $MSTR.&#8221;
With technicals in limbo and the Bitcoin debate raging on, Strategy remains one of the most polarizing stocks on the market. Who wins this round — Saylor or Schiff?
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44378673/strategy-announces-500-million-strf-preferred-stock-offering-to-boost-bitcoin-investments">Strategy Announces $500 Million STRF Preferred Stock Offering To Boost Bitcoin Investments</a></li>
</ul>
Photo: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Technicals

Offerings

$BTC

MSTR

QBTS

RGTI

Michael Saylor's Bitcoin Bet Faces Peter Schiff's Wrath: Who's Right About Strategy?

NVIDIA Announces Blackwell Ultra For AI Reasoning

Legal

NextDecade Announced U.S. Court Of Appeals For D.C. Circuit Court Issued Revision To August 2024 Judgement Removing Vacatur Risk On Federal Energy Regulatory Commission's Order

BofA Securities analyst Brad Sills reiterated a Buy rating on Salesforce, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>), <a href="https://www.benzinga.com/quote/CRM/analyst-ratings" target="_blank" rel="noreferrer noopener">with a price forecast of $400.</a>
The analyst acknowledges the growing risk of a macroeconomic slowdown caused by tariffs, which may delay the target to fiscal year 2026.
Sills writes that Agentforce could contribute an additional 2% growth in the upside scenario by the second half of fiscal year 2025, supported by the strong performance of Data Cloud, which had an annual recurring revenue of $900 million in the fourth quarter, marking a 120% year-over-year growth.
The report also highlights the potential for margin expansion and free cash flow growth driven by ongoing productivity improvements across the company.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/03/44380301/tesla-analyst-says-demand-fears-overblown-but-has-some-concerns-as-used-car-prices-plummet" rel="noreferrer noopener">Tesla Analyst Says Demand Fears &#8216;Overblown,&#8217; But Has Some Concerns As Used Car Prices Plummet</a>
The analyst maintains that Salesforce is emerging as a quality GARP stock, with consistent low-double-digit revenue growth and steady margin expansion of 50 to 100 basis points, driven by sales and marketing leverage.
Sills suggests that in a favorable scenario, Salesforce could achieve a free cash flow of $28.2 billion by fiscal year 2031, representing a 15% compound annual growth rate over five years, with a 38.8% FCF margin. This would imply an average annual margin expansion of 100 basis points from fiscal year 2025.
The primary driver of margin improvement is expected to come from sales and marketing efforts.
To achieve this, Sills highlights the importance of the sales and marketing to incremental revenue ratio as a key metric.
According to the analyst, there is significant potential for further improvement through several initiatives, such as reducing the ratio of account executives to accounts, leveraging partnerships, enhancing product packaging and using Agentforce internally within the company.
The analyst explains that the continued development of Agentforce is expected to result in negative research and development leverage, which will partly counterbalance the positive leverage from sales and marketing efforts mentioned earlier.
Price Action: CRM shares are trading lower by 0.89% to $278.74 on Tuesday.
Now Read:
<ul>
<li><a href="https://www.benzinga.com/news/25/03/44339973/trump-said-nobody-wants-to-buy-evs-2-years-ago-now-hes-endorsing-and-says-hes-buying-a-tesla-heres-what-else-hes-been-saying-about-evs" target="_blank" rel="noreferrer noopener">Trump Said ‘Nobody Wants To Buy' EVs 2 Years Ago—Now He's Endorsing Tesla At The White House</a></li>
</ul>
Photo: Shutterstock

Analyst Ratings

Salesforce's Growth Path: Analyst Predicts $28.2 Billion Free Cash Flow By 2031, But Tariffs Could Delay Target

Intel Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) shares are trading higher Tuesday after investors reacted to reports of a major leadership shift and restructuring efforts <a href="https://www.benzinga.com/trading-ideas/movers/25/03/44361645/intel-shares-surge-as-new-ceo-plans-major-overhaul-whats-going-on">under incoming CEO Lip-Bu Tan.</a>
What To Know: Reuters reported that Tan, who was previously a board member and CEO of Cadence Design Systems, is planning an aggressive overhaul of Intel's chip design, manufacturing operations and AI strategy. His plan includes further cost-cutting measures, management restructuring and a renewed push into AI chip production. Tan has been openly critical of former CEO Pat Gelsinger's execution, particularly in manufacturing decisions and Intel's failure to secure a competitive position in the AI market.
A key focus of Tan's strategy is revitalizing Intel Foundry, the company's contract chip manufacturing business, which serves clients like Microsoft and Amazon. While Intel previously aimed to challenge Taiwan Semiconductor Manufacturing Co. (TSMC) and Nvidia in AI and semiconductor production, execution missteps and a weakening market led to significant setbacks, including an annual loss of $19 billion in 2024.
Tan is expected to push for an annual AI chip release cycle, positioning Intel's next-generation Panther Lake chips—built on the company's new 18A process—as a critical test for its ability to compete. However, industry experts note that it could take years for Intel to develop AI hardware capable of rivaling Nvidia's dominance.
At an internal town hall, Tan acknowledged the need for difficult decisions to streamline Intel's operations. His leadership marks a shift toward aggressive restructuring and operational efficiency, signaling a departure from Intel's previous approach.
INTC Price Action: Intel shares were up 1.54% at $26.08 at the time of writing, according to <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072624&amp;t=be2bearmibe3na1">Benzinga pro.</a>
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="516" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18135816/Screenshot-2025-03-18-at-13.57.49-1024x516.png" alt="" class="wp-image-830082" style="width:473px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18135816/Screenshot-2025-03-18-at-13.57.49-1024x516.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18135816/Screenshot-2025-03-18-at-13.57.49-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18135816/Screenshot-2025-03-18-at-13.57.49-768x387.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18135816/Screenshot-2025-03-18-at-13.57.49.png 1512w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44379453/equity-exposure-plummets-cash-holdings-jump-as-investors-rethink-us-exceptionalism-bank-of-america-survey">Equity Exposure Plummets, Cash Holdings Jump As Investors Rethink &#8216;US Exceptionalism,&#8217; Bank Of America Survey</a></li>
</ul>
Image via Shutterstock.

Movers

INTC

Intel Shares Are On The Rise Today: What's Going On?

Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) futures have started trading on the <a href="https://www.benzinga.com/insights/analyst-ratings/25/03/44221065/a-glimpse-into-the-expert-outlook-on-cme-group-through-12-analysts">Chicago Mercantile Exchange</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>) this week, but early activity was underwhelming compared to major cryptocurrencies like Bitcoin and Ethereum.
According to a report by research firm K33, the first day of trading for Solana futures saw a total volume of $12.3 million, with open interest ending at $7.8 million.
This marked a stark contrast to Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) futures, which drew $102.7 million in volume and $20.9 million in open interest during their December 2017 debut on CME. 
Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) fared better too, recording $31 million in trading and $20 million in open interest when its futures launched in February 2021.
K33 analysts Vetle Lunde and David Zimmerman <a href="https://k33.com/research/articles/stabilizing-flow-stabilizing-market">attributed</a> the tepid performance to broader market conditions, noting that Solana's introduction came during a period of muted risk appetite and without the tailwinds of a strong bull market or a rally in alternative cryptocurrencies.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44380265/bitcoin-is-past-the-bull-cycle-peak-top-analyst-warns">Bitcoin Is &#8216;Past The Bull Cycle Peak,&#8217; Top Analyst Warns</a>
&#8220;Although Solana&#8217;s performance appears more reasonable when adjusted for its market capitalization, its absolute figures were far lower than previous futures launches,&#8221; the K33 report stated.
The analysts added that despite the subdued start, the listing does fit a pattern often associated with eventual spot ETF approvals. 
However, they cautioned that Solana's lower trading activity suggests any future ETF tied to the token may have a more modest impact on prices compared to the rally sparked by Bitcoin's spot ETF approval in early 2024.
What&#8217;s Next: The report comes at a time when several altcoin ETFs, including those for Solana, are under review by U.S. regulators.
For now, the futures market signals that institutional demand for Solana has yet to match the enthusiasm seen for Bitcoin and Ethereum during their initial futures rollouts.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/03/44378673/strategy-announces-500-million-strf-preferred-stock-offering-to-boost-bitcoin-investments">Strategy Announces $500 Million STRF Preferred Stock Offering To Boost Bitcoin Investments</a></li>
</ul>
Image: Shutterstock

$ETH

$SOL

Solana Underperforms Historical Bitcoin, Ethereum Volumes On First Day Of CME Futures Trading

J.P. Morgan analyst Lisa C. Gill, with a Neutral rating, updated estimates for Agilon Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AGL#NYSE">AGL</a>) following fourth-<a href="https://www.benzinga.com/quote/agl/analyst-ratings" target="_blank" rel="noreferrer noopener">quarter results posted last month</a>.
Last month, the company reported a fourth-quarter 2024 adjusted EPS of $(0.26), missing the consensus estimate of $(0.23). However, sales for the quarter totaled $1.52 billion, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43956121/agilon-health-reports-fourth-quarter-and-full-year-fiscal-2024-results" rel="noreferrer noopener">which is in line with expectations</a>.
The analyst&#8217;s revised estimates reflect an updated outlook on AGL&#8217;s recovery timeline based on management&#8217;s recent commentary.
With 2025 expected to be a year of transition, the company aims to address specific challenges while navigating another year of high trends, positioning itself to achieve its targets for 2026/2027, adds the analyst.
The analyst estimates revenue of $1.502 billion (vs. $1.503 billion consensus) and adjusted EBITDA of $16 million (in line with consensus) in the first quarter of FY25.
For FY25, Gill revised the revenue estimate to $5.926 billion (vs. $5.928 billion consensus) from $6.453 billion earlier while adjusted EBITDA loss estimate remains unchanged at $77 million (vs. consensus loss of $78 million).
For FY26, the analyst updated the revenue estimate to $6.594 billion (vs. consensus mean of $6.665 billion) from $7.319 billion prior and adjusted EBITDA loss estimate changes to $23 million (vs. consensus loss of $22 million) from loss of $10 million prior.
Investors can gain exposure to the stock via Fidelity Disruptive Medicine ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FMED#NASDAQ">FMED</a>) and SPDR S&amp;P Health Care Services ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHS#NYSE">XHS</a>).
Price Action: AGL shares are down 0.48% at $4.18 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44378137/cloudflare-launches-cloudforce-one-and-security-posture-management-for-real-time-threat-response" target="_blank" rel="noreferrer noopener">Cloudflare Launches Cloudforce One And Security Posture Management For Real-Time Threat Response</a></li>
</ul>
Image via Shutterstock.

Analyst Color

Equities

Reiteration

Small Cap

FMED

Agilon Health Adjusts To Recovery Phase, Analyst Is Cautious On Near-Term Fundamentals

Deep-pocketed investors have adopted a bullish approach towards Gilead Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in GILD usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for Gilead Sciences. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 55% leaning bullish and 33% bearish. Among these notable options, 5 are puts, totaling $436,483, and 4 are calls, amounting to $134,326.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $90.0 to $120.0 for Gilead Sciences over the recent three months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Gilead Sciences's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Gilead Sciences's whale trades within a strike price range from $90.0 to $120.0 in the last 30 days. 
<h3>Gilead Sciences 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742322647_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GILD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$8.35</td>
<td>$8.3</td>
<td>$8.3</td>
<td>$100.00</td>
<td>$249.0K</td>
<td>0</td>
<td align="right">339</td>
</tr>
<tr>
<td>GILD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$16.25</td>
<td>$15.4</td>
<td>$15.4</td>
<td>$120.00</td>
<td>$70.8K</td>
<td>27</td>
<td align="right">50</td>
</tr>
<tr>
<td>GILD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$2.79</td>
<td>$2.67</td>
<td>$2.68</td>
<td>$110.00</td>
<td>$49.7K</td>
<td>2.8K</td>
<td align="right">82</td>
</tr>
<tr>
<td>GILD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$1.97</td>
<td>$1.78</td>
<td>$1.78</td>
<td>$115.00</td>
<td>$40.6K</td>
<td>5.9K</td>
<td align="right">406</td>
</tr>
<tr>
<td>GILD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$8.2</td>
<td>$8.0</td>
<td>$8.2</td>
<td>$100.00</td>
<td>$37.7K</td>
<td>0</td>
<td align="right">492</td>
</tr>
</tbody>
</table>

<h3>About Gilead Sciences</h3>
Gilead Sciences develops and markets therapies to treat life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
In light of the recent options history for Gilead Sciences, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Gilead Sciences's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 4,472,451, the GILD's price is up by 0.12%, now at $112.4. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 37 days.</li>
</ul>
<h3>Professional Analyst Ratings for Gilead Sciences</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $129.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Gilead Sciences, which currently sits at a price target of $140. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Buy rating for Gilead Sciences, targeting a price of $126. 
&#x2A; An analyst from Morgan Stanley persists with their Overweight rating on Gilead Sciences, maintaining a target price of $130. 
&#x2A; An analyst from Oppenheimer has decided to maintain their Outperform rating on Gilead Sciences, which currently sits at a price target of $132. 
&#x2A; In a positive move, an analyst from Deutsche Bank has upgraded their rating to Buy and adjusted the price target to $120. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Gilead Sciences with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

GILD

Unpacking the Latest Options Trading Trends in Gilead Sciences

Financial giants have made a conspicuous bearish move on ServiceNow. Our analysis of options history for ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) revealed 23 unusual trades.
Delving into the details, we found 26% of traders were bullish, while 43% showed bearish tendencies. Out of all the trades we spotted, 14 were puts, with a value of $1,329,090, and 9 were calls, valued at $478,806.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $600.0 to $1080.0 for ServiceNow during the past quarter. 
<h3>Volume &amp; Open Interest Development</h3>
In today's trading context, the average open interest for options of ServiceNow stands at 131.59, with a total volume reaching 504.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in ServiceNow, situated within the strike price corridor from $600.0 to $1080.0, throughout the last 30 days.
<h3>ServiceNow 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742322642_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NOW</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>10/17/25</td>
<td>$52.1</td>
<td>$49.7</td>
<td>$51.1</td>
<td>$740.00</td>
<td>$511.0K</td>
<td align="right">0</td>
<td align="right">100</td>
</tr>
<tr>
<td>NOW</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$81.7</td>
<td>$77.5</td>
<td>$81.3</td>
<td>$740.00</td>
<td>$333.3K</td>
<td align="right">0</td>
<td align="right">42</td>
</tr>
<tr>
<td>NOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$12.2</td>
<td>$11.4</td>
<td>$11.4</td>
<td>$1040.00</td>
<td>$114.0K</td>
<td align="right">179</td>
<td align="right">100</td>
</tr>
<tr>
<td>NOW</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$80.6</td>
<td>$73.2</td>
<td>$77.2</td>
<td>$900.00</td>
<td>$77.2K</td>
<td align="right">716</td>
<td align="right">14</td>
</tr>
<tr>
<td>NOW</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$69.5</td>
<td>$69.0</td>
<td>$69.0</td>
<td>$830.00</td>
<td>$69.0K</td>
<td align="right">23</td>
<td align="right">10</td>
</tr>
</tbody>
</table>

<h3>About ServiceNow</h3>
ServiceNow Inc provides software solutions to structure and automate various business processes via a SaaS delivery model. The company primarily focuses on the IT function for enterprise customers. ServiceNow began with IT service management, expanded within the IT function, and more recently directed its workflow automation logic to functional areas beyond IT, notably customer service, HR service delivery, and security operations. ServiceNow also offers an application development platform as a service.
<h3>ServiceNow's Current Market Status</h3>
<ul>
<li>With a volume of 959,561, the price of NOW is down -1.96% at $826.41. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 36 days.</li>
</ul>
<h3>Professional Analyst Ratings for ServiceNow</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $1144.6.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Outperform rating on ServiceNow with a target price of $1100. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $1048. 
&#x2A; An analyst from Citizens Capital Markets has revised its rating downward to Market Outperform, adjusting the price target to $1300. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on ServiceNow with a target price of $1000. 
&#x2A; Maintaining their stance, an analyst from Canaccord Genuity continues to hold a Buy rating for ServiceNow, targeting a price of $1275. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for ServiceNow, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Spotlight on ServiceNow: Analyzing the Surge in Options Activity

On Monday, BofA Securities highlighted its monthly consumer survey of spending expectations, which included around 1,000 respondents in the <a target="_blank" href="https://www.benzinga.com/topic/economic-data" rel="noreferrer noopener">U.S. in March</a>.
The analyst notes an improvement in signs to spend on Home Improvement over the next 3 months, which has increased to 31% vs. 27% last year and has been the highest since May 2024.
Plans to buy a New Home increased slightly from 18% to 20%, but the sentiment is still low compared to the same period in 2021-2023. Plans to have a new baby have improved from 9% to 12% and are flat compared to the 2023 level.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/03/44380787/fda-grants-fast-track-review-to-johnson-johnsons-nipocalimab-for-autoimmune-disorder-that-affects-tears-saliva" rel="noreferrer noopener">FDA Grants Fast Track Review To Johnson &amp; Johnson's Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva</a>
The&nbsp;Conference Board Consumer Confidence Index&nbsp;fell sharply in February, declining 7.0 points to 98.3, marking the&nbsp;steepest drop&nbsp;since August 2021. This is the third consecutive monthly decline, bringing the index to the lower end <a target="_blank" href="https://www.benzinga.com/news/25/02/43949339/consumer-confidence-plummets-in-february-sharp-decline-marks-third-consecutive-monthly-drop" rel="noreferrer noopener">of its two-year range</a>.
The Conference Board Consumer Confidence Index is a widely watched&nbsp;economic indicator&nbsp;that measures consumer sentiment regarding the current and future state of the economy.
It is based on a monthly survey of 5,000 households, assessing perceptions of business conditions, labor markets and personal finances.
The BofA analyst notes that fewer people noticed more promotions in Electronics this March (8% vs. 10% last year), the lowest since June 2023, marking four months of decline from a peak of 13% in December 2024.
Meanwhile, more respondents say they aren't seeing an increase in discounts overall (48% vs. 42% last year), with this trend rising since November 2024, when it was 40%.
For the next 12 months, upper and lower income respondents see grocery spending increasing. Fifty percent of lower-income respondents expect an increase, the highest level since the survey launched in December 2020.
Earlier this week, the University of Michigan's March consumer confidence survey&nbsp;showed a rapid decrease&nbsp;in consumer confidence amid historically <a target="_blank" href="https://www.benzinga.com/topic/consumer-confidence" rel="noreferrer noopener">high inflation expectations</a>.
The report showed an 11% monthly-over-month drop and a 22% decline from December 2024. Meanwhile, inflation expectations jumped from 4.3% in February to 4.9% in March, the highest reading <a target="_blank" href="https://www.benzinga.com/news/25/03/44344560/horrific-report-economists-warn-consumer-confidence-collapse-signals-economic-trouble" rel="noreferrer noopener">since November 2022</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44380305/whats-going-on-with-tilray-brands-stock-today" target="_blank" rel="noreferrer noopener">Tilray's Manitoba Harvest Rolls Out Superseed Snacks At Whole Foods</a></li>
</ul>
Image via Shutterstock

Economics

General

Consumer Confidence Dips But Spending On Home Improvements And Family Planning Sees Uptick: Analyst Survey

Investors with a lot of money to spend have taken a bearish stance on Occidental Petroleum (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with OXY, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 13 uncommon options trades for Occidental Petroleum.
This isn't normal.
The overall sentiment of these big-money traders is split between 38% bullish and 46%, bearish.
Out of all of the special options we uncovered, 9 are puts, for a total amount of $669,352, and 4 are calls, for a total amount of $254,961.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $37.5 and $65.0 for Occidental Petroleum, spanning the last three months.
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Occidental Petroleum's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Occidental Petroleum's substantial trades, within a strike price spectrum from $37.5 to $65.0 over the preceding 30 days.
<h3>Occidental Petroleum Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742322636_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>OXY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$4.55</td>
<td>$4.4</td>
<td>$4.49</td>
<td>$45.00</td>
<td>$269.4K</td>
<td>264</td>
<td align="right">0</td>
</tr>
<tr>
<td>OXY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$3.35</td>
<td>$3.3</td>
<td>$3.3</td>
<td>$50.00</td>
<td>$165.0K</td>
<td>2.4K</td>
<td align="right">500</td>
</tr>
<tr>
<td>OXY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$3.3</td>
<td>$3.2</td>
<td>$3.25</td>
<td>$50.00</td>
<td>$101.0K</td>
<td>1.2K</td>
<td align="right">288</td>
</tr>
<tr>
<td>OXY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$6.9</td>
<td>$6.8</td>
<td>$6.8</td>
<td>$50.00</td>
<td>$78.2K</td>
<td>147</td>
<td align="right">2</td>
</tr>
<tr>
<td>OXY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$17.55</td>
<td>$17.4</td>
<td>$17.44</td>
<td>$65.00</td>
<td>$43.6K</td>
<td>525</td>
<td align="right">90</td>
</tr>
</tbody>
</table>

<h3>About Occidental Petroleum</h3>
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2023, the company reported net proved reserves of nearly 4 billion barrels of oil equivalent. Net production averaged 1,327 thousand barrels of oil equivalent per day in 2024 at a ratio of roughly 50% oil and natural gas liquids and 50% natural gas.
Following our analysis of the options activities associated with Occidental Petroleum, we pivot to a closer look at the company's own performance.
<h3>Where Is Occidental Petroleum Standing Right Now?</h3>
<ul>
<li>With a trading volume of 3,826,662, the price of OXY is up by 0.78%, reaching $47.63.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 49 days from now.</li>
</ul>
<h3>Expert Opinions on Occidental Petroleum</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $54.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from JP Morgan has decided to maintain their Neutral rating on Occidental Petroleum, which currently sits at a price target of $52. 
&#x2A; An analyst from UBS persists with their Neutral rating on Occidental Petroleum, maintaining a target price of $56. 
&#x2A; An analyst from Piper Sandler has decided to maintain their Neutral rating on Occidental Petroleum, which currently sits at a price target of $50. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Equal-Weight rating on Occidental Petroleum, which currently sits at a price target of $52. 
&#x2A; An analyst from Raymond James has revised its rating downward to Outperform, adjusting the price target to $64. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Occidental Petroleum, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Spotlight on Occidental Petroleum: Analyzing the Surge in Options Activity

BofA Securities analyst Rafe Jadrosich updated the price forecast for Lennar Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) to reflect the impact of the weak housing market and <a href="https://www.benzinga.com/quote/len/analyst-ratings" target="_blank" rel="noreferrer noopener">the </a><a href="https://www.benzinga.com/quote/len/analyst-ratings" target="_blank" rel="noreferrer noopener">Millrose Properties</a><a href="https://www.benzinga.com/quote/len/analyst-ratings" target="_blank" rel="noreferrer noopener"> spin-off</a>.
The analyst slashed the price forecast to $130 from $140 while retaining a Neutral rating.
Last month, the company completed the spin-off, contributing&nbsp;$5.5 billion&nbsp;in land <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/n43625476/lennar-completes-spin-off-of-millrose-properties" rel="noreferrer noopener">assets and&nbsp;$1.0 billion in cash</a>.
Jadrosich noted Lennar will pay Millrose an annual option fee of 8.5%, which is expected to be reflected in the cost of goods sold.
The analyst projected a modest net income headwind from Millrose in 2025 (~2%), which was expected to gradually rise to a 6% headwind by 2027 as the land delivered accrued more interest.
Additionally, Jadrosich expected a 30 basis point headwind to gross margin in 2025, with this impact progressively increasing to 85 basis points by 2027.
The analyst wrote Millrose spin-off lowers their tangible book value (TBV) per share forecast by approximately 17%, but it boosts the analyst&#8217;s return on tangible equity (ROTE) forecast by 240bps, 260bps, and 270bps for 2025, 2026, and 2027, respectively.
Meanwhile, Jadrosich expected stronger ROTE tailwinds after 2025 due to the timing of share repurchases.
The analyst projected a $942 million drag on free cash flow (FCF) in 2025 due to the Millrose, which includes a $442 million option payment and a $500 million land deposit related to the spin.
After this initial cash flow headwind, FCF generation is expected to improve with faster inventory turns, added the analyst.
Due to the elevated FCF headwind in 2025, Jadrosich cut the repurchase forecast down to $750 million (from $2.2 billion) but anticipated a significant increase to $2.7 billion in 2026 and $3.0 billion in 2027.
Investors can gain exposure to the stock via iShares U.S. Home Construction ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITB#BATS">ITB</a>) and John Hancock Fundamental All Cap Core ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHAC#NYSE">JHAC</a>).
LEN Price Action: Lennar shares are down 0.33% at $118.57 at publication Tuesday.
Read Next:
 • <a href="https://www.benzinga.com/25/03/44257955/analyst-turns-cautious-on-lennar-lowers-expectations-as-risks-mount-in-housing-sector" target="_blank" rel="noreferrer noopener">Lennar Analyst Moves To Sidelines, Downgrades Stock And Awaits Better Entry Point</a>
Courtesy: Lennar Corp.

Large Cap

Price Target

Real Estate

iShares Dow Jones US Homenstruction Index Fund

JHAC

BofA Securities Analyst Projects Millrose Spin-Off To Weigh On Lennar's Earnings, Cuts Price Target

On Tuesday, JP Morgan highlighted its survey related to&nbsp;Apellis Pharmaceuticals,&nbsp;Inc.&#8217;s&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) Syfovre and Astellas Pharma Inc&#8217;s (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ALPMF#OTC">ALPMF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ALPMY#OTC">ALPMY</a>) <a href="https://www.benzinga.com/general/biotech" target="_blank" rel="noreferrer noopener">Izervay</a>.
On average, surveyed physicians treated around 388 geographic atrophy patients and most of them had used Syfovre and Astellas&#8217; Izervay (~80%).
JP Morgan analyst Anupam Rama writes that the survey results point to steadier growth for Syfovre/branded geographic atrophy products over the next 12 months versus an inflection-type growth.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/03/44149348/apellis-lead-drug-pegcetacoplan-represents-differentiated-asset-jp-morgan-analyst" rel="noreferrer noopener">Apellis Lead Drug Pegcetacoplan Represents Differentiated Asset: JP Morgan Analyst</a>
Survey data indicates that perceptions of Syfovre and Izervay have remained largely unchanged before and after the Izervay CRL and label update. Syfovre is seen as slightly more effective, while Izervay has a safety advantage.
The geographic atrophy market is expected to respond well to promotional efforts. Over time, Apellis&#8217; strategy—including direct-to-consumer marketing, targeting younger physicians, increasing prescribing depth and emphasizing its unique dosing—should drive growth.
The company generated Syfovre sales of $167.8 million and $611.9 million for the fourth quarter and full year 2024, respectively.
It delivered approximately 94,000 Syfovre doses to physician practices in the fourth quarter, including approximately 89,000 commercial vials and 4,600 samples. More than 510,000 Syfovre injections, including clinical trials, are estimated to have been administered since <a href="https://www.benzinga.com/pressreleases/25/02/g44038782/apellis-pharmaceuticals-reports-fourth-quarter-and-full-year-2024-financial-results" target="_blank" rel="noreferrer noopener">launch through December 2024</a>.
Taking a cautious view, the analyst projects a longer timeline for Syfovre to reach peak sales, valuing it along with Empaveli (for PNH) at around the mid-$30s per share—still leaving room for growth from current levels.
JP Morgan maintains an Overweight rating while lowering the <a target="_blank" href="https://www.benzinga.com/quote/APLS/analyst-ratings" rel="noreferrer noopener">price target to $45 from $54</a>, based on extending time to peak and peak sales for Syfovre and adjustments to expenses.
Price Action: APLS stock is down 1.91% at $24.63 at the last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44380592/trump-eyes-approval-of-controversial-steel-merger-nippon-and-us-steel-await-key-decision" target="_blank" rel="noreferrer noopener">Trump Eyes Approval Of Controversial Steel Merger: Nippon, US Steel Await Key Decision</a></li>
</ul>
Photo: Shutterstock

Biotech

Health Care

ALPMF

ALPMY

APLS

JP Morgan Cut Apellis' Price Forecasts, Cites Longer Peak Sales Timing For Syfovre

Press Releases

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, NARI, SSY on Behalf of Shareholders

Kuehn Law Encourages VINC, NEUE, GETY, and CLBR Investors to Contact Law Firm

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, CLBR, VINC, NEUE on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TURN, DFS, GETY on Behalf of Shareholders

Getty Images and Verizon to Award $20,000 Grant to Champion Disability Representation in the Workplace

Financing

Getty Images Holdings, Inc. Announces Comprehensive Refinancing of Approximately $1.042 Billion Existing Term Loans

Getty Images to Release Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Sports

Getty Images and UEFA Renew Multi-Year Agreement

Getty Images Signs Multi-Year Photography Partnership with the National Women's Soccer League

Getty Images Reports Fourth Quarter and Full Year 2024 Results

CLBR

NARI

NEUE

TURN

VINC

Angi

Bumble

Cars.com

Trump Media & Technology Group Corp. - Warrants

Trump Media & Technology

EverQuote

FuboTV

Nextdoor Holdings, Inc. Class A Common Stock

Nextdoor Holdings

MediaAlpha

Hello Group Inc. - American Depositary Shares

Hello Gr

Outbrain

QuinStreet

Shutterstock

Taboola.com

Tripadvisor

TrueCar

trivago N.V. - American Depositary Shares

trivago

Travelzoo

Vimeo

Vtex

WEBTOON Entertainment Inc. - Common stock

Webtoon Entertainment

Yalla Group Limited American Depositary Shares, each representing one Class A Ordinary Share

Yalla Group

Yelp

Ziff Davis

Zhihu Inc. American Depositary Shares, each representing three (3) Class A Ordinary Shares

Comments

Getty Images Holdings

Getty Images Holdings (GETY) Opciones

Getty Images Holdings (NYSE:GETY) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL